Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 21 of 21 entries
Sorted by: Best Match Show Resources per page
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients.

International journal of molecular and cellular medicine

Khalilian S, Motovali-Bashi M, Rezaie H.
PMID: 32832483
Int J Mol Cell Med. 2020;9(1):33-50. doi: 10.22088/IJMCM.BUMS.9.1.33.

A major complication in treating hemophilia A is the development of neutralizing antibodies (inhibitors) against therapeutic administered factor VIII (FVIII), which occurs in approximately 20-30% of patients with severe disease. These inhibitors render FVIII replacement therapy ineffective and increase...

Cite
Khalilian S, Motovali-Bashi M, Rezaie H. Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients. Int J Mol Cell Med. 2020;9(1):33-50doi: 10.22088/IJMCM.BUMS.9.1.33.
Khalilian, S., Motovali-Bashi, M., & Rezaie, H. (2020). Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients. International journal of molecular and cellular medicine, 9(1), 33-50. https://doi.org/10.22088/IJMCM.BUMS.9.1.33
Khalilian, Sheyda, et al. "Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients." International journal of molecular and cellular medicine vol. 9,1 (2020): 33-50. doi: https://doi.org/10.22088/IJMCM.BUMS.9.1.33
Khalilian S, Motovali-Bashi M, Rezaie H. Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients. Int J Mol Cell Med. 2020;9(1):33-50. doi: 10.22088/IJMCM.BUMS.9.1.33. PMID: 32832483; PMCID: PMC7422849.
Copy Download .nbib Format: NLM
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR.
PMID: 34971849
J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21.

Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized....

Cite
Anantharaj A, Gujjar S, Verma N, et al. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021;146:105060doi: 10.1016/j.jcv.2021.105060.
Anantharaj, A., Gujjar, S., Verma, N., Khan, N. A., Shaman, H., Sharanabasava, P., Das, A., Pandey, R., Pandey, A. K., & Medigeshi, G. R. (2021). Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105060. https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj, Anbalagan, et al. "Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105060. doi: https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21. PMID: 34971849.
Copy Download .nbib Format: NLM
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR.
PMID: 34971849
J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21.

Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized....

Cite
Anantharaj A, Gujjar S, Verma N, et al. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021;146:105060doi: 10.1016/j.jcv.2021.105060.
Anantharaj, A., Gujjar, S., Verma, N., Khan, N. A., Shaman, H., Sharanabasava, P., Das, A., Pandey, R., Pandey, A. K., & Medigeshi, G. R. (2021). Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105060. https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj, Anbalagan, et al. "Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105060. doi: https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21. PMID: 34971849.
Copy Download .nbib Format: NLM
Sustained viral response hematological markers during the treatment of chronic hepatitis C infection in children.

Hepatitis monthly

Garcia-Algar O, Garriga L, Molera C.
PMID: 23087762
Hepat Mon. 2012 Sep;12(9):e6256. doi: 10.5812/hepatmon.6256. Epub 2012 Sep 30.

No abstract available.

Cite
Garcia-Algar O, Garriga L, Molera C. Sustained viral response hematological markers during the treatment of chronic hepatitis C infection in children. Hepat Mon. 2012;12(9):e6256doi: 10.5812/hepatmon.6256.
Garcia-Algar, O., Garriga, L., & Molera, C. (2012). Sustained viral response hematological markers during the treatment of chronic hepatitis C infection in children. Hepatitis monthly, 12(9), e6256. https://doi.org/10.5812/hepatmon.6256
Garcia-Algar, Oscar, et al. "Sustained viral response hematological markers during the treatment of chronic hepatitis C infection in children." Hepatitis monthly vol. 12,9 (2012): e6256. doi: https://doi.org/10.5812/hepatmon.6256
Garcia-Algar O, Garriga L, Molera C. Sustained viral response hematological markers during the treatment of chronic hepatitis C infection in children. Hepat Mon. 2012 Sep;12(9):e6256. doi: 10.5812/hepatmon.6256. Epub 2012 Sep 30. PMID: 23087762; PMCID: PMC3475134.
Copy Download .nbib Format: NLM
Liver failure associated with benzbromarone: A case report and review of the literature.

World journal of clinical cases

Zhang MY, Niu JQ, Wen XY, Jin QL.
PMID: 31367632
World J Clin Cases. 2019 Jul 06;7(13):1717-1725. doi: 10.12998/wjcc.v7.i13.1717.

BACKGROUND: Benzbromarone is a uricosuric agent that reduces proximal tubular reabsorption of uric acid. Because of hepatotoxicity, it has been withdrawn from the market in Europe. Recently, some benefit-risk assessments of benzbromarone suggest that benzbromarone has greater benefits than...

Cite
Zhang MY, Niu JQ, Wen XY, et al. Liver failure associated with benzbromarone: A case report and review of the literature. World J Clin Cases. 2019;7(13):1717-1725doi: 10.12998/wjcc.v7.i13.1717.
Zhang, M. Y., Niu, J. Q., Wen, X. Y., & Jin, Q. L. (2019). Liver failure associated with benzbromarone: A case report and review of the literature. World journal of clinical cases, 7(13), 1717-1725. https://doi.org/10.12998/wjcc.v7.i13.1717
Zhang, Ming-Yuan, et al. "Liver failure associated with benzbromarone: A case report and review of the literature." World journal of clinical cases vol. 7,13 (2019): 1717-1725. doi: https://doi.org/10.12998/wjcc.v7.i13.1717
Zhang MY, Niu JQ, Wen XY, Jin QL. Liver failure associated with benzbromarone: A case report and review of the literature. World J Clin Cases. 2019 Jul 06;7(13):1717-1725. doi: 10.12998/wjcc.v7.i13.1717. PMID: 31367632; PMCID: PMC6658378.
Copy Download .nbib Format: NLM
Unexpectedly High Prevalence of Hepatitis C Virus Infection, Southern Laos.

Emerging infectious diseases

Black AP, Khounvisith V, Xaydalasouk K, Sayasinh K, Sausy A, Muller CP, Hübschen JM.
PMID: 34932463
Emerg Infect Dis. 2022 Jan;28(1):256-259. doi: 10.3201/eid2801.211307.

During 2017-2019, a total of 88/753 (11.7%) of patients 5-90 years of age in hospitals in Saravan Province, Laos, were seropositive for hepatitis C virus antibodies. Viral RNA was found in 44 samples. Sequencing showed high diversity within genotype...

Cite
Black AP, Khounvisith V, Xaydalasouk K, et al. Unexpectedly High Prevalence of Hepatitis C Virus Infection, Southern Laos. Emerg Infect Dis. 2022;28(1):256-259doi: 10.3201/eid2801.211307.
Black, A. P., Khounvisith, V., Xaydalasouk, K., Sayasinh, K., Sausy, A., Muller, C. P., & Hübschen, J. M. (2022). Unexpectedly High Prevalence of Hepatitis C Virus Infection, Southern Laos. Emerging infectious diseases, 28(1), 256-259. https://doi.org/10.3201/eid2801.211307
Black, Antony P, et al. "Unexpectedly High Prevalence of Hepatitis C Virus Infection, Southern Laos." Emerging infectious diseases vol. 28,1 (2022): 256-259. doi: https://doi.org/10.3201/eid2801.211307
Black AP, Khounvisith V, Xaydalasouk K, Sayasinh K, Sausy A, Muller CP, Hübschen JM. Unexpectedly High Prevalence of Hepatitis C Virus Infection, Southern Laos. Emerg Infect Dis. 2022 Jan;28(1):256-259. doi: 10.3201/eid2801.211307. PMID: 34932463; PMCID: PMC8714196.
Copy Download .nbib Format: NLM
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR.
PMID: 34971849
J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21.

Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized....

Cite
Anantharaj A, Gujjar S, Verma N, et al. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021;146:105060doi: 10.1016/j.jcv.2021.105060.
Anantharaj, A., Gujjar, S., Verma, N., Khan, N. A., Shaman, H., Sharanabasava, P., Das, A., Pandey, R., Pandey, A. K., & Medigeshi, G. R. (2021). Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105060. https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj, Anbalagan, et al. "Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105060. doi: https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021 Dec 21;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21. PMID: 34971849; PMCID: PMC8687718.
Copy Download .nbib Format: NLM
Clinical Trials of Oncolytic Viruses in Breast Cancer.

Frontiers in oncology

Carter ME, Koch A, Lauer UM, Hartkopf AD.
PMID: 35004328
Front Oncol. 2021 Dec 23;11:803050. doi: 10.3389/fonc.2021.803050. eCollection 2021.

Breast cancer is the second most common kind of cancer worldwide and oncolytic viruses may offer a new treatment approach. There are three different types of oncolytic viruses used in clinical trials; (i) oncolytic viruses with natural anti-neoplastic properties;...

Cite
Carter ME, Koch A, Lauer UM, et al. Clinical Trials of Oncolytic Viruses in Breast Cancer. Front Oncol. 2021;11:803050doi: 10.3389/fonc.2021.803050.
Carter, M. E., Koch, A., Lauer, U. M., & Hartkopf, A. D. (2021). Clinical Trials of Oncolytic Viruses in Breast Cancer. Frontiers in oncology, 11803050. https://doi.org/10.3389/fonc.2021.803050
Carter, Mary E, et al. "Clinical Trials of Oncolytic Viruses in Breast Cancer." Frontiers in oncology vol. 11 (2021): 803050. doi: https://doi.org/10.3389/fonc.2021.803050
Carter ME, Koch A, Lauer UM, Hartkopf AD. Clinical Trials of Oncolytic Viruses in Breast Cancer. Front Oncol. 2021 Dec 23;11:803050. doi: 10.3389/fonc.2021.803050. eCollection 2021. PMID: 35004328; PMCID: PMC8733599.
Copy Download .nbib Format: NLM
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR.
PMID: 34971849
J Clin Virol. 2022 Jan;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21.

Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infections have not been characterized....

Cite
Anantharaj A, Gujjar S, Verma N, et al. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2021;146:105060doi: 10.1016/j.jcv.2021.105060.
Anantharaj, A., Gujjar, S., Verma, N., Khan, N. A., Shaman, H., Sharanabasava, P., Das, A., Pandey, R., Pandey, A. K., & Medigeshi, G. R. (2022). Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105060. https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj, Anbalagan, et al. "Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2022): 105060. doi: https://doi.org/10.1016/j.jcv.2021.105060
Anantharaj A, Gujjar S, Verma N, Khan NA, Shaman H, Sharanabasava P, Das A, Pandey R, Pandey AK, Medigeshi GR. Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses. J Clin Virol. 2022 Jan;146:105060. doi: 10.1016/j.jcv.2021.105060. Epub 2021 Dec 21. PMID: 34971849; PMCID: PMC8687718.
Copy Download .nbib Format: NLM
Showing 13 to 21 of 21 entries